We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




New Rapid-Live Screening Microscopy Technique Enables Early Detection of Treatment-Resistant Cancer Cells

By LabMedica International staff writers
Posted on 27 Sep 2023
Print article
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)

Chemotherapy serves as an effective tool in the fight against cancer, yet some cancer cells can evade treatment by going into a dormant state known as senescence. These so-called therapy-induced senescent (TIS) cells can become not just resistant to treatment but also potentially more harmful, even metastasizing. Early identification of TIS cells could be crucial in stopping their progression, but current detection techniques aren't quick or accurate enough. Now, new advanced microscopy techniques may offer a solution, allowing healthcare providers to identify these cells early on and adapt treatment plans accordingly.

A team of researchers at Johns Hopkins University (Baltimore, MD, USA) used a combination of three state-of-the-art, label-free microscopy methods—coherent Raman scattering, multi-photon absorption, and optical diffraction tomography—to examine TIS cells in their natural setting. This approach is unlike traditional methods and gave the scientists the ability to look at the cells' form, internal structure, and both physical and chemical properties during their entire life cycle.

The use of these advanced microscopy methods uncovered significant transformations within the TIS cells. For instance, within a day, the cells' mitochondria—the "energy factories" inside them—had repositioned themselves. By the 72-hour mark, the cells had started to excessively produce fatty molecules known as lipids and had become flatter and larger. This in-depth analysis helped the researchers establish a detailed timeline of these cellular changes. According to the team, their novel rapid-live screening microscopy methods offer great potential for advancing cancer research.

"Our work demonstrates the potential to transform anticancer treatment research," said Ishan Barman, an associate professor of mechanical engineering at Johns Hopkins Whiting School of Engineering. "Integrating these microscopy methods could help clinicians make more informed, timely treatment decisions."

Related Links:
Johns Hopkins University 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
D-Dimer Test
Epithod 616 D-Dimer Kit
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Lactose Intolerance Test
RIDAGENE Lac Intol

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: Scientists have discovered a new amyloid-forming protein in neurodegenerative disease (Photo courtesy of 123RF)

Discovery of Rogue Protein Paves Way for Diagnostic Test to Detect Early-Onset Dementia

Neurodegenerative disorders are often marked by the buildup of amyloid filament inclusions of specific proteins in the brain. These proteins are critical in diagnosing and treating the associated diseases.... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Three examples of Anthrobots with hair-like cilia in yellow (Photo courtesy of Gizem Gumuskaya)

Tiny Biological Robot Healers Built From Human Cells Could Recognize Bacteria

In a pioneering study, researchers have developed microscopic biological robots, termed Anthrobots, from human tracheal cells. These tiny robots, varying in size from the width of a human hair to the tip... Read more

Technology

view channel
Image: Made-to-order diagnostic tests may soon be on the horizon (Photo courtesy of McGill University)

Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read more

Industry

view channel
Image: Covaris offers instruments, consumables, and reagents for high-throughput genomic and proteomic analysis (Photo courtesy of Covaris)

PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform

PerkinElmer, Inc. (Waltham, MA, USA), a global analytical services and solutions provider has acquired Covaris (Woburn, MA, USA), a developer of solutions to empower life science innovations.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.